Generex is a biotechnology and pharmaceutical company that develops and commercializes drug delivery systems and technologies for metabolic and immunological diseases. The company was founded in 1983 in Miramar Beach, Florida, United States.
The company also looks to make strategic business decisions that allows them to provide management services, organize a network of pharmacies, clinical laboratories, and medical companies.
Along with its subsidiary, NuGenerex Immune-Oncology, Generex Biotechnology Corporation have launched a development platform for the development of a COVID-19 vaccine.
The company is looking to launch their vaccine using a li-key vaccine platform. The company has also signed a contract with EpiVax to use their tools in order to predict epitopes that will be used to generate peptide vaccines against the coronavirus. The companies together have identified hotspots in the amino acid sequences of the COVID-19 virus. The company will send their amino acids to China for the testing of the peptides in blood samples.
Eric von Hofe
Generex Biotechnology | Crunchbase
Generex Ii-Key Technology for Development of COVID-19 Vaccine Featured in Media
March 11, 2020
Press Release: Generex Signs Contract with EpiVax to Develop Ii-Key Peptide Vaccines to Address the Coronavirus Pandemic - EpiVax, Inc. - Informatics and Immunology
March 4, 2020
Documentaries, videos and podcasts
CoronaVirus Cure (Joseph Moscato & Dr. Eric Von Hofe of Generex Biotechnology Corporation) Ep. #040
Miramar Beach, Florida, United States
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.
- CoronavirusCDC Coronavirus: Coronaviruses are common throughout the world. They can infect people and animals. Five different coronaviruses can infect people and make them sick. They usually cause mild to moderate upper-respiratory illness.
- VaccineBiological preparation that improves immunity to a particular disease